9 February, 2022

The new European harmonization of clinical trials, an opportunity to attract more investment to Spain

Since yesterday, the new Clinical Trials Information System (CTIS) has been operational, which centralizes processes with the aim of speeding up these studies Our country starts […]
3 February, 2022

Spain can benefit from the new European harmonization of clinical trials

The new Clinical Trials Information System (CTIS), which centralizes processes with the aim of speeding up these studies, is now operational Source: With the entry […]
24 January, 2022

Seven out of ten drugs in clinical development are ‘first in class’.

A report on the research pipeline of global pharmaceutical companies highlights the importance of this ‘first-in-class’ share for patients with unmet medical needs. It captures notable […]
13 December, 2021

“The pandemic has shown that more Autonomous Communities can host clinical trials of drugs, which is hopeful for many patients”

More than 50% of the trials with new treatments are currently concentrated in Madrid and Barcelona Spain, a benchmark in clinical research, should also bet on […]
17 November, 2021

The AEMPS publishes the memorandum of ethics committees for drug research

Source: The Spanish Agency for Medicines and Health Products (AEMPS) has published the ‘Memorandum of collaboration between the ethics committees of research with medicines (CEIm) […]
4 November, 2021

The MD Anderson Cancer Center in Madrid inaugurates one of the largest Phase I Clinical Trials units in Europe

Source: The foundation works to eradicate cancer worldwide through clinical research, teaching and information to the population This Wednesday, November 3, MD Anderson Cancer Center […]
21 June, 2021

Farmaindustria estimates the investment in 2020 of pharmaceutical companies in research at 39,000 million

Source: Farmaindustria, the employers’ association of the innovative pharmaceutical industry in Spain, has highlighted the role of this sector in Europe “as one of the […]
8 June, 2021

The medicine, health, social and economic value

Biomedical innovation cannot be considered an expense, but rather an investment that redounds in the medium and long term in health systems and in society as […]
21 May, 2021

The investment of the pharmaceutical industry in R&D grows in 2020 despite the pandemic

Via: The pharmaceutical industry investment in R&D has increased during 2020 despite the coronavirus pandemic, but the productivity of clinical trials remains below average. This […]
20 May, 2021

Spain, a country of reference in conducting clinical trials

Via: Clinical trials mobilize financial resources, allow health professionals to add research experience to their care activity and provide patients with early access to new […]
10 May, 2021

The pharmaceutical industry has almost 90 drugs under development against antimicrobial resistance

Researchers at pharmaceutical companies are working to develop innovative antibacterial treatments, such as bacteriophages, live therapeutics, and monoclonal antibodies. The development period for new antimicrobials can […]
6 May, 2021

“Europe has the challenge of regaining ground lost to the US and Asia in drug research” “

In just two decades, the European Union has gone from leading global biomedical R&D to being the origin of only 23% of new drugs, while 47% […]
27 April, 2021

Digitization in clinical research advances for the benefit of patients

The pandemic has prompted the digitization of some clinical trial processes, but questions remain to be resolved in the globalized management of health data Farmaindustria defends […]
15 April, 2021

Observational studies with drugs published in the Spanish Trial Registry

  Source: The Spanish Agency for Medicines and Health Products (AEMPS) has communicated that Royal Decree 957/2020, of November 3, which regulates observational studies with […]
17 March, 2021

Spain launched 44 clinical trials for cardiovascular diseases in 2020

Pharmacological treatments, together with heart-healthy lifestyles, are the factors that contribute the most to improving the control of these pathologies The pharmaceutical industry has 600 investigational […]
11 March, 2021

Promoting the use of biomarkers improves cancer diagnosis and treatment

A new study evaluates the availability, quality and reimbursement of these tests in the European Union It proposes short and long-term measures to move towards precision […]
4 March, 2021

20% of clinical trials in Spain are already focused on rare diseases

The European Regulation on Orphan Medicines of the year 2000 has been the key in this research launch A quarter of the annual approvals of new […]
23 February, 2021

Clinical trials: this is how drugs and vaccines are designed

Medications and vaccines don’t come out of nowhere. They are not done in a rush and they are not due to commercial gimmicks. They are the […]
5 February, 2021

Cancer: the fight is not stopped by the covid; 4 out of 10 investigational drugs are antitumor

Source: https: Cancer continues to be one of the main fronts of the fight for drug research. On the occasion of tomorrow’s World Cancer Day […]
26 January, 2021

CARTs effective for solid tumors, not just blood cancers

An American study indicates that these cells can fight breast, colon and lung cancer Source: A new study, led by researchers at UT Southwestern (UTSW) […]
14 December, 2020

Why might the development of a new drug take more than 10 years?

Source: New drugs are responsible for 73% of the prolongation of life expectancy in developed countries and have managed to solve more and more diseases. […]
9 December, 2020

The pharmaceutical industry once again sets a record for investment in R&D in Spain

Source: The sector has registered an investment in research and development of 1,211 million euros in 2019, 5.2% more than the previous year In these […]
30 November, 2020

The Royal Decree that regulates observational studies with medicines for human use approved

Source: Royal Decree 957/2020, of November 3, establishes the conditions that must be met to proceed with the evaluation, performance and monitoring of observational studies […]
19 November, 2020

Eight drug projects of small Spanish companies attract the interest of pharmaceutical companies

New meeting of the Farma-Biotech program, which brings start-ups and research groups into contact with national and international pharmaceutical companies to promote preclinical research and facilitate […]
9 November, 2020

Regulatory alignment and mutual recognition for the manufacture of medicines, needs of the pharmaceutical industry in the face of ‘Brexit’

Pharmaceutical companies are working to ensure seamless access to medicines ahead of the UK’s exit from the EU, due in January Farmaindustria and the British Embassy […]
6 November, 2020

Takeda launches a website that groups all its clinical trials

So, in an exercise of transparency, anyone can have access to this data Carmen Montoto, Takeda Medical Director in Spain Source: As part of its […]
23 October, 2020

Farmaindustria bets on digitization to consolidate Spain in drug trials

In the workshop “Digital challenges in the management of clinical trials”, organized by Farmaindustria, its attendees have shown their commitment to digitization to help Spain consolidate […]
21 October, 2020

BMS celebrates the first international forum aimed at the research community of Spain and Portugal

The objective of this meeting has been to present the latest advances in the area of Oncology with experts of national and international origin and to […]
20 October, 2020

Research in breast cancer: more survival and better quality of life

Nine out of ten women diagnosed in Spain survive to 5 years The development of more precise, effective treatments with fewer side effects, together with the […]
5 October, 2020

Covid-19 has delayed cancer clinical trial programs

  Source: María Blasco recalls that investment in science “is not even at the levels prior to 2010” Scientists gathered at the meeting ‘A new […]